Skip to main content
Clinical Trials/NL-OMON30391
NL-OMON30391
Not yet recruiting
Phase 2

Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy - Assessment of biomarkers in FSHD

niversitair Medisch Centrum Sint Radboud0 sites35 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
muscle disease
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
35
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • FSHD patients: clinically affected patients with a genetically confirmed diagnosis, moderate severity of the disease, informed consent.
  • Heatlhy volunteers: informed consent

Exclusion Criteria

  • All subjects: kidney or liverproblems (present or past), diabetes, wheelchair bound. MR contra\-indication: pacemaker, cerebral clips, metal splinters, neuro stimulator, cardiac arythmias, epilepsy, severe claustrofobia, pregnancy.
  • Healthy volunteers: skeletal muscle problems or disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy - Assessment of biomarkers in FSHDHealthy volunteers. Later the protocol will be applied to Facioscapular humeral dystrophy and/or other muscular dystrophies in general.MedDRA version: 8.1Level: LLTClassification code 10011328Term: Creatine
EUCTR2006-006776-37-NLRadboud University Nijmegen Medical Center
Recruiting
Not Applicable
Search of biomarkers for metabolic abnormalities of cholesterol by comprehensive analysis of cholesterol metabolites in human body fluidInborn error of metabolism (Niemann-Pick disease type C, 3beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase (3beta-HSD) defficiency, lysosomal storage disorder, etc), hepatobiliary diaseses (steatosis, NAFLD, NASH, ALD, hepatitis B, hepatitis C, primary biliary cirrhosis, cholangitis, hepatic carcinoma)
JPRN-UMIN000017343Department of Pharmaceutical Sciences, Tohoku university hospital60
Completed
Not Applicable
Development of Biomarkers for Early Detection of Gastric Cancer Using Metabolomics
KCT0005597Korea University Anam Hospital40
Not yet recruiting
Not Applicable
The study on metabolic and inflammatory biomarkers and gut microbiota in overweight Thai adultsto investigate and compare the metabolic, inflammatory biomarkers and gut microbiota composition of normal and overweight in a nationally representative sample of Thai adults. Then, associations between will be analysed gut microbial concentrations, clinical-biochemical blood parameters and dietary patterns will be assessed.Overweight, metabolic biomarkers, inflammatory biomarkers, gut microbiota, dietary pattern
TCTR20220204007Fundamental fund Kasetsart University60
Not yet recruiting
Not Applicable
Metabolomics analysis to discover biomarkers of glaucomaPrimary open-angle glaucoma
JPRN-UMIN000049651Tohoku University1,400